Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 563

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 563
---
’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

|                                                      |     | December 31, 
 2024         |           |     | December 31, 
         2023 |
|:-----------------------------------------------------|:----|:-------------|----------:|:----|-------------:|
| Formation costs and other operating expenses         |     | $            | 2,612,483 |     |    1,744,855 |
| Interest earned on investments held in Trust Account |     | $            | 3,056,533 |     |    4,024,613 |

The key measures of segment profit or loss reviewed by our CODM are interest earned on investments held in Trust Account and formation costs and other operating expenses. The CODM reviews interest earned on investments held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Formation costs and operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews formation costs and operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. NOTE 13. SUBSEQUENT EVENTS The Company evaluated events that have occurred after the balance sheet date up through the date the financial statements was issued. Based upon the review, management did not identify, other than what has already been disclosed as part of the financial statement footnotes, any subsequent events that would have required adjustment or disclosure in the financial statements.

F-62

Report of Independent Registered Public Accounting Firm To theboard of directors and shareholders of OmnigenicsAI Corp Opinion on the Combined Financial Statements We have audited the accompanying combined statement of financial position of OmnigenicsAI Corp (the “Company”) as of June 30, 2024 and 2023, and the related combined statements of operations, of other comprehensive loss, of changes in shareholders’ deficit and of cash flows for the years then ended, including the related notes (collectively referred to as the “combined financial statements”). In our opinion, the